An IPO surge in 4Q25 shows a recognisable equity story with scale can still spark investor demand - https://t.co/UMH8ch8G1o. We have also updated our free-to-access reporting calendar in this month's newsletter - https://t.co/A1Qh9yFk7K. #IPO#Financial#CapitalRaising
Exciting to see Cyclopharm’s (ASX:CYC) incredible growth story showcased on Sky News Australia! Their breakthrough Technegas technology is transforming functional lung imaging and improving respiratory care worldwide. 👉 https://t.co/ERT15fQGBB
#MedTech#Technegas#Cyclopharm
We look back across 2025 to see Trump Tariffs, AI aspirations and ESG expectations as big areas of focus in the past year - https://t.co/9Fy5mbVRsw. #IR#TrumpTariffs#AI#ESG#2025review
Congrats to our client, Eagers Automotive Limited, on the completion of a successful Retail Entitlement Offer, supported by our shareholder engagement team. The offer raised ~$310 million with 82.1% support. #CapitalRaising#RetailEntitlementOffer#ShareholderEngagement
It’s been a huge week at AML3D 🇺🇸
We officially opened our U.S. Tech Facility in Stow, Ohio — advancing the AUKUS alliance and U.S. submarine programs with cutting-edge metal 3D printing.
✅ Onshoring defense manufacturing
✅ Creating high-skilled jobs
✅ Strengthening supply chains
#AL3 #WAM #ARCEMY #AUKUS #AdvancedManufacturing #Ohio #AmericaMakes
Australian tech. Allied strength.
AML3D has started manufacture of their cutting-edge submarine components in the USA.
It’s a strategic investment in America and Australia’s shared security interests, and another leap forward for AUKUS partner cooperation.
We take a look at who is ultimately responsible for share trading activity and why the ASX is flexing on disclosure rules, click https://t.co/XnSH5WyCqU to find out more. #ShareTrading#MarketDisclosure#ASX#InvestorRelations
IRO's advised to be more assertive about Board access and cyber security breaches hit record highs. Learn more in our monthly newsletter - https://t.co/Q5pNyFiXY3 #InvestorRelations#Cybersecurity#Databreach
Our MedTech client Cyclopharm (ASX:CYC) hosts its AGM on Friday, 30 May, 2025. CEO, James McBrayer took to the ausbiz airwaves to present the investment case, https://t.co/ziMUWAuQlB, and discuss growth https://t.co/6An9CRkYpm #Cyclopharm#MedTech#Technegas#NuclearMedicine
ASIC promises pragmatic and proportionate enforcement as it updates of sustainability reporting guidance, find out more in FIRST Advisers monthly update - https://t.co/amrqR698zj #investorrelations#Sustainability#corpcomms
With overall trust in Australia's business, Government, media and NGOs in decline it is CEO's who are being called to action. This month's blog focuses on the 25th annual Edelman Trust report - https://t.co/rzbAglCGAm #IRO#CorpComms#ESG#SocietalValue
Data driven investor targeting; cybersecurity breaches and Australian ESG activism are revealed as the attention grabbers amongst the FIRST Edition blogs in 2024. See for yourself here: https://t.co/1YdwiWMKkx #investorrelations#cybersecurity#ESG#Activism
Cybersecurity takes centre stage with new doxing laws and the Lockbit ransomware gang smashed. So what does the most recent notifiable data breaches update reveal about listed companies cyber resilience? https://t.co/YPNYBGeapJ #cybersecurity#investorrelations#cyberattacks
As the recent rate rising cycle stabilises we look at how companies can maximise their access to capital markets and track when companies are reporting financial results - https://t.co/DxYHRCY00p #capitalmarkets#financialreporting#investorrelations
As the Cop28 global climate summit gets underway we look at the new Australian climate disclosure standards and the best FIRST Advisers blogs as we review 2023 - https://t.co/VC6DEpWvT7 #2023year#climatechange#interestrates#ISSB#ifrs#2023trends
With AGM season just around the corner we review some of the key trends for investors and proxy advisers as well as looking at how vote tracking adds value, click here - https://t.co/rsNZG2uusb #AGM#Investors#IR#ESG